Summary
Dendritic cells (DCs) play a key role in the orchestration of immune reactions. Manipulation of DC function through genetic manipulation for vaccine development provides a multitude of applications for active immunotherapy of cancer and chronic infections. Several laboratories have shown that lentiviral vectors (LVs) are efficient and consistent tools for ex vivo gene manipulation of DCs and their precursors. LVs integrate in the genome of target cells resulting in persistent and stable transgene expression, and gene delivery does not result in cytostatic or nonspecific adverse immunomodulatory reactions. Mouse, macaque, and human DCs are efficiently transduced with LVs, allowing preclinical vaccination studies to be gradually implemented into clinical trials. This chapter describes HIV-1-derived LV transduction used for ex vivo gene delivery of marking genes, antigens, and immunomodulatory molecules into mouse and human hematopoietic precursors and DCs. With the perspective of bioengineering DCs from the inside-out, we also describe a one-hit LV transduction method for constitutive expression of GM-CSF and IL-4 genes, which allows self-differentiation of mouse and human hematopoietic precursor cells into highly viable and potent DCs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Banchereau, J., Steinman, R.M. (1998) Dendritic cells and the control of immunity. Nature 392:245–252
O'Neill, D.W., Adams, S., Bhardwaj, N. (2004) Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 104:2235–2246
Figdor, C.G., de Vries, I.J., Lesterhuis, W.J., Melief, C.J. (2004) Dendritic cell immunotherapy: mapping the way. Nat Med 10:475–480
Van den Bosch, G.A., Ponsaerts, P., Vanham, G., Van Bockstaele, D.R., Berneman, Z.N., Van Tendeloo, V. F. (2006) Cellular immunotherapy for cytomegalovirus and HIV-1 infection. J Immunother 29:107–121
Sallusto, F., Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109–1118
Inaba, K., Steinman, R.M., Pack, M.W., Aya, H., Inaba, M., Sudo, T., Wolpe, S., Schuler, G. (1992) Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med 175:1157–1167
Heidenreich, S. (1999) Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides. J Leukoc Biol 65:737–743
Lutz, M.B., Suri, R.M., Niimi, M., Ogilvie, A.L., Kukutsch, N.A., Rossner, S., Schuler, G., Austyn, J.M. (2000) Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 30:1813–22
Schuler, G., Steinman, R.M. (1997) Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med 186:1183–1187
Ribas, A., Butterfield, L.H., Glaspy, J.A., Economou, J.S. (2003) Current developments in cancer vaccines and cellular immunotherapy. J Clin Oncol 21:2415–2432
Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., Alber, G. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184:747–752
Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J.P., van Kooten, C., Liu, Y.J., Rousset, F., Saeland, S. (1994) The CD40 antigen and its ligand. Annu Rev Immunol 12:881–922
Ribas, A., Butterfield, L.H., Amarnani, S.N., Dissette, V.B., Kim, D., Meng, W.S., Miranda, G.A., Wang, H.J., McBride, W.H., Glaspy, J.A., Economou, J.S. (2001) CD40 crosslinking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells. Cancer Res 61:8787–93
Lau, R., Wang, F., Jeffery, G., Marty, V., Kuniyoshi, J., Bade, E., Ryback, M.E., Weber, J. (2001) Phase I trial of intravenous peptidepulsed dendritic cells in patients with metastatic melanoma. J Immunother 24:66–78
Dullaers, M., Thielemans, K. (2006) From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy. J Gene Med 8:3–17
Van den Driessche, T., Thorrez, L., Naldini, L., Follenzi, A., Moons, L., Berneman, Z., Collen, D., Chuah, M.K. (2002) Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100:813–822
Follenzi, A., Battaglia, M., Lombardo, A., Annoni, A., Roncarolo, M.G., Naldini, L. (2004) Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 103:3700–3709
Schroers, R., Sinha, I., Segall, H., SchmidtWolf, I.G., Rooney, C.M., Brenner, M.K., Sutton, R.E., Chen, S.Y. (2000) Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol Ther 1:171–179
Gruber, A., Kan-Mitchell, J., Kuhen, K.L., Mukai, T., Wong-Staal, F. (2000) Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T- lymphocyte response in vitro. Blood 96:1327–1333
Chinnasamy, N., Chinnasamy, D., Toso, J.F., Lapointe, R., Candotti, F., Morgan, R.A., Hwu, P. (2000) Ef ficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors. Hum Gene Ther 11:1901–1909
Granelli-Piperno, A., Zhong, L., Haslett, P., Jacobson, J., Steinman, R.M. (2000) Dendritic cells, infected with vesicular stomatitis virus-pseudotyped HIV-1, present viral antigens to CD4+ and CD8+ T cells from HIV-1-infected individuals. J Immunol 165:6620–6626
Dyall, J., Latouche, J.B., Schnell, S., Sadelain, M. (2001) Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes. Blood 97:114–121
Salmon, P., Arrighi, J.F., Piguet, V., Chapuis, B., Zubler, R.H., Trono, D., Kindler, V. (2001) Transduction of CD34+ cells with lentiviral vectors enables the production of large quantities of transgene-expressing immature and mature dendritic cells. J Gene Med 3:311–320
Esslinger, C., Romero, P., MacDonald, H.R. (2002) Efficient transduction of dendritic cells and induction of a T-cell response by thirdgeneration lentivectors. Hum Gene Ther 13:1091–1100
Rouas, R., Uch, R., Cleuter, Y., Jordier, F., Bagnis, C., Mannoni, P., Lewalle, P., Mar tiat, P., Van den Broeke, A. (2002) Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints. Cancer Gene Ther 9:715–724
Koya, R.C., Kasahara, N., Favaro, P.M., Lau, R., Ta, H.Q., Weber, J.S., Stripecke, R. (2003) Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery. J Immunother 26:451–460
Veron, P., Boutin, S., Bernard, J., Danos, O., Davoust, J., Masurier, C. (2006) Efficient transduction of monocyte- and CD34+-derived Langerhans cells with lentiviral vectors in the absence of phenotypic and functional maturation. J Gene Med 8:951–961
Metharom, P., Ellem, K.A., Schmidt, C., Wei, M.Q. (2001) Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma. Hum Gene Ther 12:2203–2213
Koya, R.C., Kimura, T., Ribas, A., Rozengurt, N., Lawson, G.W., Faure-Kumar, E., Wang, H.J., Herschman, H., Kasahara, N., Stripecke, R. (2007) Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines. Mol Ther 15:971–980
Lizee, G., Gonzales, M.I., Topalian, S.L. (2004) Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells. Hum Gene Ther 15:393–404
Breckpot, K., Dullaers, M., Bonehill, A., van Meirvenne, S., Heirman, C., de Greef, C., van der Bruggen, P., Thielemans, K. (2003) Lentivirally transduced dendritic cells as a tool for cancer immunotherapy. J Gene Med 5:654–667
Firat, H., Zennou, V., Garcia-Pons, F., Ginhoux, F., Cochet, M., Danos, O., Lemonnier, F.A., Langlade-Demoyen, P., Charneau, P. (2002) Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy. J Gene Med 4:38–45
Zarei, S., Abraham, S., Arrighi, J.F., Haller, O., Calzascia, T., Walker, P.R., Kundig, T.M., Hauser, C., Piguet, V. (2004) Lentiviral transduction of dendritic cells confers protective antiviral immunity in vivo. J Virol 78:7843–7845
Chen, X., Wang, B., Chang, L.J. (2006) Induction of primary anti-HIV CD4 and CD8 T cell responses by dendritic cells transduced with self-inactivating lentiviral vectors. Cell Immunol 243:10–18
Buffa, V., Negri, D.R., Leone, P., Borghi, M., Bona, R., Michelini, Z., Compagnoni, D., Sgadari, C., Ensoli, B., Cara, A. (2006) Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo. Viral Immunol 19:690–701
Koya, R.C., Weber, J.S., Kasahara, N., Lau, R., Villacres, M.C., Levine, A.M., Stripecke, R. (2004) Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitro. Hum Gene Ther 15:733–748
Dull, T., Zufferey, R., Kelly, M., Mandel, R.J., Nguyen, M., Trono, D., Naldini, L. (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463–8471
Stripecke, R., Koya, R.C., Ta, H.Q., Kasahara, N., Levine, A.M. (2003) The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors. Blood Cells Mol Dis 31:28–37
Breckpot, K., Corthals, J., Heirman, C., Bonehill, A., Michiels, A., Tuyaerts, S., De Greef, C., Thielemans, K. (2004) Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cells. Hum Gene Ther 15:562–573
Gorski, K.S., Shin, T., Crafton, E., Otsuji, M., Rattis, F.M., Huang, X., Kelleher, E., Francisco, L., Pardoll, D., Tsuchiya, H. (2003) A set of genes selectively expressed in murine dendritic cells: utility of related cis-acting sequences for lentiviral gene transfer. Mol Immunol 40:35–47
Cui, Y., Golob, J., Kelleher, E., Ye, Z., Pardoll, D., Cheng, L. (2002) Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood. 99:399–408
Follenzi, A., Ailles, L.E., Bakovic, S., Geuna, M., Naldini, L. (2000) Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25:217–222
Sirven, A., Pflumio, F., Zennou, V., Titeux, M., Vainchenker, W., Coulombel, L., Dubart-Kupperschmitt, A., Charneau, P. (2000) The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 96:4103–4110
Mangeot, P.E., Duperrier, K., Negre, D., Boson, B., Rigal, D., Cosset, F.L., Darlix, J.L. (2002) High levels of transduction of human dendritic cells with optimized SIV vectors. Mol Ther 5:283–290
Acknowledgments
The author would like to thank the previous and current members of her group and of the UCLA Vector Core for the hard work and support. This work was supported by The Margareth E. Early Research Trust, Stop Cancer, and NIH grants (UCLA Center for in vivo Imaging in Cancer Biology/2P50-CA086306-06, Rebirth/DFG and SFB 738/DFG.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Stripecke, R. (2009). Lentiviral Vector-Mediated Genetic Programming of Mouse and Human Dendritic Cells. In: Baum, C. (eds) Genetic Modification of Hematopoietic Stem Cells. Methods In Molecular Biology™, vol 506. Humana Press. https://doi.org/10.1007/978-1-59745-409-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-59745-409-4_11
Publisher Name: Humana Press
Print ISBN: 978-1-58829-980-2
Online ISBN: 978-1-59745-409-4
eBook Packages: Springer Protocols